Front Office Sports and PointsBet Launch Premium Betting Newsletter for the Modern, Sophisticated Bettor
Front Office Sports, a leading multiplatform media brand built for the modern sports consumer, together with PointsBet, the fastest growing online sportsbook in the U.S., are teaming up to deliver a groundbreaking partnership that brings together the unique strengths of both properties.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220907005003/en/
Front Office Sports, a leading multiplatform media brand built for the modern sports consumer, together with PointsBet, the fastest growing online sportsbook in the U.S., are teaming up to deliver a groundbreaking partnership that brings together the unique strengths of both properties. (Graphic: Front Office Sports)
By leveraging Front Office Sports’ core tech and content competencies, PointsBet will now be able to deliver its audience of sophisticated bettors the latest news, biggest bets, and hottest boosts to subscribers’ inboxes. The digital destination for bettors looking for an edge.
“We’re excited to partner with Front Office Sports for a first-of-its-kind newsletter that’s made for the modern bettor,” said Liam Roecklein, Senior Vice President of Content for PointsBet. “PointsBet’s ‘The Hustle’ will provide insider news, insights, unique offers, and more beginning this fall for the start of football season. Sophisticated bettors are always looking for an edge, and we’re confident ‘The Hustle’ will be a must-read.”
This unique partnership between Front Office Sports and PointsBet also will allow for multiple areas of value creation including growth, monetization, and audience engagement.
“We’re thrilled to be able to provide our expertise in developing and executing a custom newsletter for one of the leaders in the sports betting category,” said Andrew Budkofsky, Chief Revenue Officer, Front Office Sports. “Millions of people will now be able to enjoy a professionally produced newsletter providing incredible insight and perspective in betting.”
The newsletter, created by Front Office Sports’ in-house content studio, will launch three times a week (Sunday, Monday, and Thursday) starting on Thursday September 8th. The plan will be to expand the newsletter’s frequency to five times weekly in the fall.
ABOUT FRONT OFFICE SPORTS
Front Office Sports is a multiplatform media brand built for the modern sports consumer. FOS reaches an influential and rapidly expanding audience of over 20M people per month across our newsletters, site, podcasts, and social channels.
FOS is backed by SC.Holdings, a New York-based investment and strategic advisory firm, and Crain Communications, one of the largest privately owned business media companies with 21 leading business, trade, and consumer brands in North America, Europe, and Asia.
In 2021, Front Office Sports was named one of Fast Company’s Most Innovative Companies and has had its client work recognized as finalists for various industry awards.
ABOUT POINTSBET
PointsBet is a corporate bookmaker listed on the Australian Stock Exchange with operations in Australia, the United States, Canada, and Ireland. PointsBet has developed a scalable cloud-based wagering platform through which it offers its clients innovative sports and racing wagering products, advance deposit wagering on racing (ADW), and iGaming.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220907005003/en/
Contact information
MEDIA
Front Office Sports – Stephanie Connolly – stephanie@fos.company
PointsBet – Janelle Laignelet – janelle.laignelet@pointsbet.com
About Business Wire
Business WireSubscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TUM Races to Victory at ASPIRE’s Inaugural Abu Dhabi Autonomous Racing League at Yas Marina Circuit28.4.2024 13:57:00 CEST | Press release
TUM (Technical University of Munich) from Germany, claimed victory at the inaugural Abu Dhabi Autonomous Racing League (A2RL), at Yas Marina Circuit on Saturday (April 27). As the cars lined up on the grid, with antennae, sensors, AI capabilities, and drive-by-wire systems instead of human drivers, eight teams vied with one another over two days of races and challenges. TUM beat back the competition with its coding and engineering skills in a world-first, four-car race finale, to claim the winner’s share of US$2.25 million prize pot. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240428292385/en/ TUM Races to Victory at ASPIRE’s Inaugural Abu Dhabi Autonomous Racing League at Yas Marina Circuit - (Photo: AETOSWire) Bringing a science experiment to the racetrack, the inaugural race pushed the boundaries of autonomous technology while adding entertainment value to extreme sports at an unprecedented scale. A2RL drew over 10,000
ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 02:09:00 CEST | Press release
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines,today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio har
HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 22:06:00 CEST | Press release
HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY
Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio
Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom